Cite
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
MLA
Susan G. Arbuck, et al. “Relationships between Drug Activity in NCI Preclinical in Vitro and in Vivo Models and Early Clinical Trials.” British Journal of Cancer, vol. 84, no. 10, May 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ae9e3d550c887c015376d7064abb6c40&authtype=sso&custid=ns315887.
APA
Susan G. Arbuck, S Schepartz, S. Decker, Daniel W. Zaharevitz, Edward A. Sausville, Michaele C. Christian, J M Venditti, Melinda G. Hollingshead, Larry Rubinstein, J. I. Johnson, & S Kalyandrug. (2001). Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. British Journal of Cancer, 84(10).
Chicago
Susan G. Arbuck, S Schepartz, S. Decker, Daniel W. Zaharevitz, Edward A. Sausville, Michaele C. Christian, J M Venditti, et al. 2001. “Relationships between Drug Activity in NCI Preclinical in Vitro and in Vivo Models and Early Clinical Trials.” British Journal of Cancer 84 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ae9e3d550c887c015376d7064abb6c40&authtype=sso&custid=ns315887.